Shenzhen China Health , a unit of the group , is to acquire a 18.57 % stake worth CNY2.19bn ( $ 332 m ) in blood products maker , Biopharmaceutical & Healthcare , as it looks to expand in other sectors along with its presence in the health care industry .
Shenzhen Shipping Health, a unit of Kaisa Group, is to buy a 18.57% stake worth CNY2.19bn ($332m) in blood products producer Zhenxing Biopharmaceutical & Chemical, as it looks to expand in other sectors along with its presence in the health care industry.